Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: J Allergy Clin Immunol. 2020 Feb 5;146(1):222–226. doi: 10.1016/j.jaci.2020.01.039

Figure 1. (A).

Figure 1

Figure 1

Post-bronchodilator FEV1%predicted (B) Absolute Change in Post-Bronchodilator FEV1%predicted and (C) Exacerbations at baseline and each annual visit for subjects stratified by sputum Eos + Neu differential categories determined at baseline. *High Eos+High Neu vs Low Eos+Low Neu, p<0.05; †High Eos+High Neu vs Low Eos+High Neu, p<0.05; + High Eos+High Neu vs High Eos+Low Neu, p<0.05